Novartis Ag (NVS) Other financing activities (as filed) (2009 - 2026)
Novartis Ag's Other financing activities (as filed) was $2 million in Q3 2026, down 90.9% from $22 million a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Other financing activities (as filed) (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's Other financing activities (as filed) was -$20 million through Sep 30, 2026; for FY2025, it was -$575 million.
- In earlier years, Other financing activities (as filed) was -$469 million in FY2024, $3.23 billion in FY2023, -$181 million in FY2022 and -$183 million in FY2021.
- Quarterly Other financing activities (as filed) has moved between -$281 million (Q2 2025) and $150 million (Q4 2023) over five years.
- Compared with a year earlier, Other financing activities (as filed) was higher in 1 of the last four quarters, with growth averaging 3.4%.
- The best year-over-year quarter for Other financing activities (as filed) over five years was Q1 2026 (growth of 239.1%); the worst was Q2 2022 (a decline of 97.1%).
- Per Business Quant data, NVS's Other financing activities (as filed) in the three quarters before Q3 2026 was -$67 million (Q2 2026), $78 million (Q1 2026) and -$33 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | -67.00 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | -33.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | -281.00 Mn |
| Mar 31, 2025 | 23.00 Mn |
| Dec 31, 2024 | 28.00 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Jun 30, 2024 | -84.00 Mn |
| Mar 31, 2024 | -11.00 Mn |
| Dec 31, 2023 | 150.00 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 53.00 Mn |
| Dec 31, 2022 | -161.00 Mn |
| Sep 30, 2022 | 32.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Dec 31, 2021 | 6.00 Mn |
API Access
Novartis Ag Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();